Erik Ostrowski
Chief Executive Officer at AVROBIO, INC.
Net worth: 37 485 $ as of 2024-03-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Philip Donenberg | M | 63 | 6 years | |
Ian Clark | M | 62 | 6 years | |
Azadeh Golipour | M | - | 8 years | |
Christopher Paige | M | 71 | 8 years | |
Steven Avruch | M | 63 | 5 years | |
Annalisa Jenkins | M | 58 | 6 years | |
Tuomo Tapani Pätsi | M | 60 | 1 years | |
Philip Vickers | M | 64 | 5 years | |
Bruce Booth | M | 49 | 8 years | |
Gail Farfel | M | 60 | 4 years | |
Vesa Tapio Karvonen | M | 52 | 2 years | |
Anita Treohan | F | - | - | |
Essra Ridha | M | 41 | 3 years | |
Kirsten Dupuis | F | - | 8 years | |
Scott Gottesman | M | - | - | |
Birge Berns | M | - | 1 years | |
Christine Roth | F | 61 | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Geoff MacKay | M | 57 | 8 years | |
Matti Esa Manner | M | 71 | 19 years | |
Stephen Davies | M | 74 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 15 years |
Kim Warren | M | - | 5 years | |
Anne Michelle Whitaker | F | 56 | 2 years | |
David Wurzer | M | 65 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 4 years |
Barry James Price | M | 80 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 12 years |
Gregory Brown | M | 70 | 6 years | |
Valerie Lynne Andrews | F | 64 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 5 years |
Leopoldo Giampaolo Zambeletti | M | 55 | 8 years | |
Christopher Mason | M | 66 | 7 years | |
Frank Armstrong | M | 67 | 9 years | |
David Roblin | M | 57 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 3 years |
Ralf H. Rosskamp | M | 71 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 2 years |
Diana M. Escolar | M | 52 | - | |
Richard Pfeifer | M | - | - | |
Kim Raineri | M | - | 2 years | |
Matt Arnold | M | - | - | |
Christopher Gerry | M | - | 3 years | |
Juuso Vakkuri | M | - | - | |
Jennifer Smith-Parker | F | - | 1 years | |
Georgette Verdin | F | - | - | |
Toni Haenninen | M | - | 4 years | |
Josie Yang | M | - | - | |
Holly May | F | - | - | |
Sean O'Bryan | M | - | - | |
Gabriel Cohn | M | 65 | 2 years | |
Birgitte Volck | M | 61 | 2 years | |
Jonathon Tinsley | M | 65 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 13 years |
Monique da Silva | F | - | - | |
Deanna M. Petersen | F | 62 | 7 years | |
James O'Brien | M | 57 | 1 years | |
Jim Mellon | M | 68 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 2 years |
Julia Balanova | F | - | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 29 | 56.86% |
Finland | 14 | 27.45% |
United Kingdom | 8 | 15.69% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Erik Ostrowski
- Personal Network